CNAT - Conatus Pharmaceuticals misses by $0.02 misses on revenue May, 02 2019 04:58 PM Conatus Pharmaceuticals Conatus Pharmaceuticals (NASDAQ:CNAT): Q1 GAAP EPS of -$0.14 misses by $0.02.Revenue of $7M (-28.1% Y/Y) misses by $1.26M.Press ReleaseMore news on: Conatus Pharmaceuticals Inc., Earnings news and commentary, Healthcare stocks news, ,